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Abstract
Objectives To analyze alterations in left ventricular (LV)myo-
cardial T1 times in patients with pulmonary hypertension
(PH) and to investigate their associations with ventricular
function, mass, geometry and hemodynamics.
Methods Fifty-eight patients with suspected PH underwent
right heart catheterization (RHC) and 3T cardiac magnetic
resonance imaging. Ventricular function, geometry and mass
were derived from cine real-time short-axis images.
Myocardial T1 maps were acquired by a prototype modified
Look-Locker inversion-recovery sequence in short-axis orien-
tations. LV global, segmental and ventricular insertion point
(VIP) T1 times were evaluated manually and corrected for
blood T1.
Results Septal, lateral, global and VIP T1 times were signifi-
cantly higher in PH than in non-PH subjects (septal, 1249
±58 ms vs. 1186±33 ms, p<0.0001; lateral, 1190±45 ms
vs. 1150±33 ms, p=0.0003; global, 1220±52 ms vs. 1171
± 29 ms, p<0.0001; VIP, 1298 ± 78 ms vs. 1193± 31 ms,
p<0.0001). In PH, LV eccentricity index was the strongest
linear predictor of VIP T1 (r=0.72). Septal, lateral and global
T1 showed strong correlations with VIP T1 (r=0.81, r=0.59
and r=0.75, respectively).
Conclusions In patients with PH, T1 times in VIPs and in the
entire LV myocardium are elevated. LV eccentricity strongly
correlates with VIP T1 time, which in turn is strongly associ-
ated with T1 time changes in the entire LV myocardium.
Key Points
• Native T1 mapping detects left ventricular myocardial alter-
ations in pulmonary hypertension
• In pulmonary hypertension, native T1 times at ventricular
insertion points are increased
• These T1 times correlate strongly with left ventricular
eccentricity
• In pulmonary hypertension, global and segmental myocar-
dial T1 times are increased
• Global, segmental and ventricular insertion point T1 times
are strongly correlated
Keywords T1mapping . Cardiacmagnetic resonance
imaging . Pulmonary hypertension . Right heart
hemodynamics . Cardiac function
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FOV Field of view
GRAPPA Generalized auto-calibrating partially
parallel acquisition
IVS Intraventricular septum
K Myocardial blood normalization coefficient
LGE Late gadolinium enhancement
LV Left ventricle
LVEI Left ventricular eccentricity index
LVMMI Left ventricular muscle mass index
LVCR Left ventricular curvature ratio
mBP Mean systemic blood pressure
MOLLI Modified Look-Locker inversion recovery
mPAP Mean pulmonary arterial pressure
PAH Pulmonary arterial hypertension
PH Pulmonary hypertension
PAWP Pulmonary arterial wedge pressure
PVR Pulmonary vascular resistance
RAP Right atrial pressure
RHC Right heart catheter
RV Right ventricle
RVMMI Right ventricular muscle mass index
sBP Systolic systemic blood pressure
sPAP Systolic pulmonary arterial pressure
SVI Stroke volume index
TI Inversion time
VIP Ventricular insertion points
VMR Ventricular mass ratio
Introduction
Patients with pulmonary hypertension (PH) are at risk for
progressive heart failure [1, 2]. The extent of late gadolinium
enhancement at the ventricular insertion points (VIPs) and
intraventricular septum (IVS) on cardiac magnetic resonance
(CMR) imaging of these patients has been identified as a
marker of progression and clinical worsening of disease
[3–6]. As late gadolinium enhancement (LGE) imaging de-
tects focal myocardial lesions but cannot assess diffuse myo-
cardial remodelling [7], it remains unclear whether myocardial
alterations in PH are restricted to the VIPs and IVS, or if the
global left ventricular (LV) myocardium is affected by chronic
right heart pressure overload [8, 9].
Myocardial T1 relaxation time mapping is an emerging
technique for tissue characterization that provides information
about tissue composition on a standardized scale [7, 10].
Increasing with myocardial collagen content, myocardial T1
times have the potential to identify both focal and diffuse
myocardial fibrosis on global as well as regional levels
[11–13]. We hypothesized that in patients with PH, T1 maps
could depict myocardial alterations at the VIPs and IVS and, if
present, in the entire LV myocardium.
The aim of the present study was, therefore, to assess LV
global, segmental and VIP T1 times in patients with normal
and elevated mean pulmonary arterial pressure, and to inves-
tigate their correlations with ventricular function, mass, geom-
etry and hemodynamic parameters.
Methods
Study population
This prospective, explorative study was approved by the local
ethical review board, and all subjects gave written informed
consent. Patients with contraindications to magnetic reso-
nance imaging were not enrolled.
FromNovember 2012 to January 2015, a total of sixty-four
patients with suspected PH underwent right heart catheteriza-
tion (RHC) and non-contrast CMR imaging. Patients with
known cardiomyopathies or PH owing to left heart diseases
[1] were excluded from analysis. The remaining fifty-eight
patients underwent both investigations within 7 ± 10 days.
Demographic characteristics of the study population are given
in Table 1.
Twenty healthy subjects (10 women; mean age of all
subjects, 33 ± 12 years; age range, 21–54 years) without
any history of cardiovascular and/or pulmonary disease
and with normal left and right ventricular cardiac function
and myocardial mass [14] also underwent MR imaging so
that the 3T myocardial T1 blood normalization coefficient
could be determined [15].
Right heart catheterization
RHC was performed in free breathing in the supine position
with a 7F quadruple-lumen, balloon-tipped, flow-directed
Swan-Ganz catheter (Baxter Healthcare Corp., Irvine, CA,
USA) using the transjugular approach. The parameters obtain-
ed included mean, systolic and diastolic pulmonary arterial
pressure (mPAP, sPAP and dPAP, respectively), pulmonary
arterial wedge pressure (PAWP), right atrial pressure (RAP)
and pulmonary vascular resistance (PVR) with the cardiac
output measured by thermodilution. Moreover, mean, systolic
and diastolic systemic blood pressure (mBP, sBP and dBP,
respectively) were measured during RHC. RHC and systemic
blood pressure parameters are summarized under the term
hemodynamic parameters.
PH was diagnosed in thirty-five patients. Sixteen subjects
with mPAP<21 mmHg (mPAP=16±3 mmHg; range, 11–
19 mmHg) and seven patients who demonstrated borderline
mPAP (range, 21–24 mmHg) were labelled as non-PH sub-
jects. The RHC-based clinical classifications and hemody-
namic parameters of the study population are summarized in
Table 1. mPAP of patients with pulmonary arterial
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hypertension (PAH; PH group 1) compared to mPAP of PH
patients without PAH (non-PAH PH; PH groups 3–5) did not
differ significantly (mPAP=46±17 mmHg vs. mPAP=42
±8 mmHg, p=0.35).
CMR imaging
CMR imaging was performed on a 3 T MR scanner
(Magnetom Trio, Siemens Healthcare, Erlangen, Germany)
using a phased-array 6-channel body matrix coil together with
a spine matrix coil. Subjects were investigated in the supine
position. For functional assessment, ECG-gated balanced
steady-state free-precession (bSSFP) cine real-time short-axis
images covering the entire right and left ventricles from base
to apex were obtained under free breathing. Typical imaging
parameters were temporal resolution, 46–51 ms; echo time,
1.0 ms; flip angle, 50–60°; field of view (FOV), 248–
315×360 mm2; voxel size, 4.1–4.8×2.8×8.0 mm3.
A single breath-hold, ECG-gated modified Look-Locker
inversion recovery (MOLLI) prototype sequence with single-
shot bSSFP readout, motion correction and automatic T1
map generation was used to acquire basal, mid-ventricular
and apical short-axis myocardial T1 maps in systole [10,
16]. The MOLLI scheme consisted of the acquisition of a
total of seven images. Five images were acquired after an
initial non-slice-selective inversion pulse at an inversion time
of TI=90 ms to 4×RR+90 ms. After a recovery phase of 5
heartbeats, 2 further images were measured after a second
non-slice-selective inversion pulse at TI =170 ms and RR+
170 ms. Protocol parameters of the bSSFP readout were
repetition time, 2.6 ms; echo time, 1.1 ms; flip angle, 35°;
FOV, 315 × 360 mm2; voxel size, 2.1 × 1.4 × 8.0 mm3.
Generalized auto-calibrating partially parallel acquisition
(GRAPPA) with a parallel acquisition factor of 2 and partial
Fourier 6/8 reconstruction were employed to minimize
acquisition time within each cardiac interval.
CMR image analysis
Quantification of LV and right ventricular (RV) end-diastolic
volume (EDV), end-systolic volume (ESV), ejection fraction
(EF), stroke volume (SV) and muscle mass (MM) was per-
formed with Argus function software (Siemens Healthcare,
Erlangen, Germany) by manual segmentation of myocardial
end-diastolic and end-systolic epicardial and endocardial bor-
ders including papillary muscles and trabeculae to the myo-
cardium. EDV, ESV, SV and MM were normalized to body
surface area (BSA). Indexed quantities are indicated with BI^,
and CI denotes the cardiac index. The ventricular mass ratio
(VMR) was calculated as the ratio RVMM/LVMM.
The LV eccentricity index (LVEI) was obtained from an
end-diastolic mid-chamber short-axis image as the ratio of
the LV diameters parallel and perpendicular to the IVS [17].
Maximal LV curvature ratio (LVCR) was calculated from the
ratio of interventricular septal to free-wall curvature on a basal
short-axis image in the cardiac phase with maximum IVS
displacement [18].
Two readers independently evaluated the T1 maps.
Segmental LV myocardial T1 times were derived by manu-
ally outlining T1 maps according to the American Heart
Association (AHA) segmentation scheme, carefully exclud-
ing blood pool, papillary muscles, trabeculae and epicardial
structures (Fig. 1). Regions were drawn to be as large as
possible while avoiding inclusion of subendocardial blood
and subepicardial tissue boundaries. Regions of artificially
high or low T1 values due to improper motion correction or
partial volume effects were excluded from segmentation.
Global LV myocardial T1 times were calculated as means
of segmental values. Septal and lateral myocardial T1 times
were calculated as means of septal (segments 2/3/8/9/14) and
lateral (segments 5/6/11/12/16) myocardial segments.
Regional VIP T1 times were defined as the mean T1 times
of a region of maximum T1 values between the segments 1/2,
3/4, 7/8, 9/10, 13/14 and 14/15, respectively. The extent of
each region was adapted by targeting its T1 time standard
deviation (SD) to be comparable with the SDs in lateral myo-
cardial segments (resulting in regions of typically 10–
15 pixels). VIP T1 time was defined as the mean of anterior
Table 1 Demographic characteristics and RHC data of the study
population. Parameters are given as means ± standard deviations.
p values refer to comparison of mean values of non-PH and PH
subjects. The PH groups are defined as follows: 1 - pulmonary arterial
hypertension (PAH), 3 - PH due to lung diseases and/or hypoxia, 4 -
chronic thromboembolic PH, and 5 - PH with unclear and/or multifacto-
rial mechanisms
Parameter All Non-PH PH p
No. of patients 58 23 35
PH group 1 patients 18
PH group 3 patients 7
PH group 4 patients 8
PH group 5 patients 2
No. of female/male patients 36/22 16/7 20/15
age (years) 62 ± 15 59 ± 12 64± 16 0.23
BSA 1.8 ± 0.2 1.8 ± 0.2 1.8 ± 0.2 0.93
HF (beats/min) 72± 12 68 ± 11 74± 12 0.052
mBP (mmHg) 84± 12 87 ± 10 83± 13 0.27
sBP (mmHg) 125 ± 20 132 ± 21 120 ± 17 0.016
dBP (mmHg) 68± 12 69 ± 10 68± 14 0.71
mPAP (mmHg) 34± 17 18 ± 4 44± 13 <0.0001
sPAP (mmHg) 55± 26 29 ± 6 72± 19 <0.0001
dPAP (mmHg) 22± 12 11 ± 3 29± 11 <0.0001
PAWP (mmHg) 9 ± 3 8 ± 3 9 ± 3 0.090
RAP (mmHg) 7 ± 4 5 ± 2 8 ± 4 0.0011
PVR (Wood units) 6.3 ± 5.1 2.0 ± 1.1 9.1 ± 4.7 <0.0001
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septal and posterior septal basal, mid-ventricular and apical
short-axis VIP T1 times. Blood T1 time was derived from the
mean of regions of interest drawn in the blood pool of the LV
cavity in basal, mid-ventricular and apical short-axis slices.
Regions were drawn to be as large as possible while avoiding
subendocardial blood-tissue boundaries, papillary muscles
and trabeculae.
All measured segmental, myocardial and VIP T1 times
were normalized to the mean blood T1 time of the study pop-
ulation (T1blood,mean) assuming a common linear increase (k,
blood normalization coefficient) of T1 times with the T1 of
blood [15]. Given measured segmental, myocardial, VIP T1
and blood T1 (T1blood), blood - normalized segmental, myo-
ca rd i a l and VIP T1 t imes were ob ta ined f rom
T1normalized=T1+k · (T1blood,mean – T1blood), with k estimated
from healthy subjects.
Myocardial T1 blood normalization coefficient
Basal, mid-ventricular and apical short-axis T1 maps were
acquired in 20 healthy subjects. The MOLLI protocol and
the method of evaluating T1maps usedwere the same as those
described above. Blood normalization coefficient k was deter-
mined as the common slope of multiple linear regression of
observer-averaged segmental T1 time with observer-averaged
blood T1 time and AHA segments as a discrete independent
variable.
Statistical analysis
Mean values are given together with SDs; correlation coeffi-
cients are specified together with 95 % confidence intervals
(CIs), if appropriate. Statistical analysis was performed using
NCSS (Hintze, J. 2008, NCSS, LLC. Kaysville, UT, USA). A
significance level of 0.05 was employed for statistical tests; no
multiple comparison adjustment was applied.
The assumption of segment independence of the slope of
multiple linear regression of observer-averaged segmental T1
time with observer-averaged blood T1 time and AHA seg-
ments in healthy volunteers was analyzed by including an
interaction term in the model and testing the significance of
this term via an F test. Segment dependence of intercepts of
the multiple linear regression model was investigated by test-
ing the significance of the AHA segment term of the model.
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Fig. 1 Segmentation of myocardial T1 maps. LV myocardium was
segmented into 16 segments (solid gray contours) according to the
AHA segmentation scheme (gray dotted lines). Regions at anterior
septal and posterior septal ventricular insertions points (VIPs, white
dotted contours) were drawn to be as large as possible around maximal
T1 times in VIPs, targeting standard deviations (SDs) comparable with
lateral myocardium. Blood T1 was derived from a region of interest (b,
white solid contour) drawn in the blood pool of the left ventricular cavity
Interobserver variability for determination of T1 times in
patients was calculated from paired measurements of the two
readers as within-subject SD in variance component analysis
and additionally as intraclass correlation coefficient rIC.
Averages of T1 measurements of the two readers were used
in subsequent analysis.
PH and non-PH patient group means as well as means of
PAH and non-PAH PH patients were compared by a t test or
Aspin–Welch unequal variance test if appropriate.
Relationships between various T1 times and ventricular func-
tion, geometry, myocardial mass and hemodynamic parame-
ters were investigated by correlation and linear regression
analysis.
Moreover, the following multiple linear regression models
were studied: The PH dependence of slopes and intercepts of
linear regression models of septal, lateral and global myocar-
dial T1 times on VIP T1 time were analyzed by adding the
presence of PH as a discrete variable (with and without inter-
action) to the corresponding linear regression models and af-
terwards testing the significance of these additionally included
terms. Bilinear regressions of VIP T1 time with LVEI and the
other ventricular function, geometry, myocardial mass and
hemodynamic parameters were studied for PH patients to an-
alyze if one of the additional parameters can explain a signif-
icant amount of residual variation in VIP T1 time. Finally, all
bilinear and trilinear regression models of septal, lateral and
global myocardial T1 times with ventricular function, geom-
etry, myocardial mass or hemodynamic parameters were ana-
lyzed for all patients and PH patients only to investigate if one
of the independent parameter combinations can explain vari-
ations of septal, lateral and global myocardial T1 times similar
to VIP T1 time.
Results
Ventricular function, mass and geometry indices
Ventricular function, mass and geometrical parameters were
evaluated in all subjects and compared between patient
groups. Table 2 summarizes the results of the comparisons
as well as the correlations between the measured parameters
and mPAP.
Myocardial T1 blood normalization coefficient
All myocardial segments (n=320) in T1 maps from the 20
healthy subjects were evaluable. Multiple linear regression of
segmental myocardial T1 values with blood T1 time and AHA
segments revealed multiple correlation coefficient R=0.66.
Intercepts differed significantly for segments (p<0.0001),
whereas slopes did not (p = 0.071). The common slope
k=0.30 was employed as the blood normalization coefficient
in the study population.
Blood T1 time
Interobserver variability for the determination of blood T1
time was 10 ms (rIC=0.99). Mean blood T1 times of 1890
±91 ms for non-PH and 1822±101 ms for PH subjects dif-
fered (p=0.011). Myocardial T1 times were normalized to the
study population’s mean blood T1 time of 1849±102 ms.
Segmental, septal, lateral and global myocardial T1 times
T1 times were evaluated in 927 of 928 myocardial segments.
One segment (0.1 %) was excluded from analysis due to close
proximity to the LV outflow tract. Interobserver variability
levels for determination of segmental, septal, lateral and glob-
al myocardial T1 values were 15 ms (rIC = 0.96), 8 ms
(rIC = 0.98), 9 ms (rIC = 0.97) and 7 ms (rIC = 0.98),
respectively.
Mean segmental myocardial T1 times are given in Fig. 2a.
In all segments, T1 values were higher in patients with PH
than in those without PH; the difference was significant in 15
segments. Mean septal, lateral and global myocardial T1 times
were significantly higher in patients with PH (Fig. 3). Neither
segmental, septal, lateral nor global myocardial T1 times dif-
fered significantly between PAH and non-PAH PH groups.
Moreover, septal, lateral and global T1 times correlated
strongly with each other: r=0.94 (global vs. septal; 95 % CI
0.91–0.97), r=0.92 (global vs. lateral; 95 % CI 0.87–0.95),
and r=0.79 (septal vs. lateral; 95 % CI 0.67–0.87).
Table 2 Ventricular function, mass and geometry indices and their
correlations with mPAP. p values describe the significance level of the
difference in mean values of non-PH and PH subjects
Parameter All r Non-PH PH p
RVEDVI 109 ± 40 0.28 91± 23 122 ± 44 0.0010
RVESVI 62± 37 0.43 43± 15 75 ± 41 <0.0001
RVSVI 47± 14 -0.35 48± 10 46 ± 15 0.62
RVEF 46± 13 -0.63 54± 7 41 ± 14 <0.0001
RVCI 3.3 ± 1.0 -0.14 3.2 ± 0.9 3.4 ± 1.1 0.44
RVMMI 46± 22 0.63 31± 8 56 ± 22 <0.0001
LVEDVI 68± 19 -0.17 71± 17 66 ± 20 0.34
LVESVI 24± 12 0.09 24± 10 25 ± 14 0.69
LVSVI 43± 12 -0.37 47± 10 41 ± 12 0.045
LVEF 65± 10 -0.29 67± 7 63 ± 11 0.11
LVCI 3.0 ± 0.6 -0.23 3.1 ± 0.6 3.0 ± 0.7 0.47
LVMMI 52± 13 0.06 51± 17 53 ± 11 0.64
VMR 0.90± 0.34 0.65 0.65± 0.22 1.06 ± 0.31 <0.0001
LVEI 1.19± 0.19 0.76 1.07± 0.07 1.27 ± 0.19 <0.0001
LVCR 0.16± 0.67 -0.87 0.79± 0.17 -0.26 ± 0.52 <0.0001
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VIP T1 times
Three of the 348 regional VIP T1 times (0.9 %) were rated as
non-evaluable and excluded from the analysis: 2 VIPs due to
artefacts caused by incorrect motion correction and 1 VIP due
to close proximity to the LVoutflow tract. Interobserver var-
iability levels for the assessment of regional and (averaged)
VIP T1 times were 25 ms (rIC=0.93) and 14 ms (rIC=0.97),
respectively.
T1 times of anterior septal and posterior septal basal, mid-
ventricular and apical VIPs were significantly higher in pa-
tients with PH than in those without PH (Fig. 2b). The mean
VIP T1 time of the PH group was significantly higher than
that of the non-PH group (Fig. 3). No significant differences
were found in VIP T1 times of PAH and non-PAH PH
patients.
VIP T1 values correlated with septal, lateral and global
myocardial T1 times. Correlation coefficients and linear re-
gression lines for all patients are given in Fig. 4. Neither slopes
nor intercepts of the regression lines depended significantly on
the presence of PH. Correlation coefficients of VIP T1 time
with septal, lateral and global myocardial T1 times for PH
patients were r=0.81 (95 % CI 0.64–0.90), r=0.59 (95 %
CI 0.32–0.77) and r=0.75 (95 % CI 0.54–0.86), respectively.
Correlations of T1 times with hemodynamic, ventricular
function, mass and geometrical parameters
Correlations of septal, lateral, global and VIP T1 times with
hemodynamic, ventricular function, mass and geometrical pa-
rameters for all patients and PH patients are summarized in
Table 3.
LVEI was the strongest correlate of VIP T1 time for pa-
tients with PH; the corresponding linear regression of VIP T1
time on LVEI is shown in Fig. 5. The only parameter
reaching significance additional to LVEI in bilinear regres-
sion was RVCI: The multiple correlation coefficient was
R = 0.76 with partial correlation coefficients of r = 0.72
(p<0.0001) and r= -0.34 (p=0.049) for LVEI and RVCI,
respectively.
Moreover, there was no bilinear or trilinear combination of
hemodynamic, ventricular function, mass or geometrical
Fig. 2 Mean segmental
myocardial and regional VIP T1
times for all, non-PH and PH
patients. Mean values and
standard deviations (in ms) of
segmental myocardial (a) and
regional VIP (b) T1 times are
specified in bull’s-eye plots.
Segments for which T1 values
differed significantly between
patients with and without PH are
in gray; p values for the
comparison of regional VIP T1
times are indicated
Fig. 3 Box plot of septal, lateral, global and VIP T1 values in patients
with and without PH. Mean values and standard deviations are specified
in ms; p values are given above brackets for the corresponding
comparisons of non-PH and PH subjects
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parameters, which correlated stronger with septal, lateral or
global myocardial T1 times than VIP T1 time, both for all
patients and PH patients.
Impact of blood normalization
Non-normalized T1 values in all segments and of anterior
septal and posterior septal basal, mid-ventricular and apical
VIPs were higher in patients with PH than in those without
PH. Whereas the difference remained significant for all VIPs,
the differences of segmental T1 times were significant only in
seven segments (2–4, 8–10, 14).
Accordingly, mean septal, lateral and global non-
normalized myocardial T1 times as well as mean non-
normalized VIP T1 time were higher in patients with PH than
in those without PH. The difference for the lateral wall, how-
ever, was not significant (Fig. 6).
Correlation coefficients of non-normalized VIP T1 time
with septal, lateral and global non-normalized myocardial
T1 times remained similar to the blood normalized values
[all patients, r=0.86 (95 % CI 0.77–0.91), r=0.67 (95 % CI
0.50–0.79), and r=0.80 (95 % CI 0.68–0.88), respectively;
PH patients, r=0.84 (95 % CI 0.70–0.92), r=0.67 (95 % CI
0.43–0.82), and r=0.79 (95 % CI 0.61–0.89), respectively].
LVEI remained the strongest correlate of non-normalized VIP
T1 time for patients with PH (r=0.65, 95 % CI 0.39–0.80).
Discussion
The major findings of the present study were that 1) septal,
lateral, global and VIP T1 times were significantly higher in
patients with PH than in those without PH; 2) VIP T1 time
was the strongest linear predictor of septal, lateral and global
T1 times; and 3) in patients with PH, LVEI was the strongest
linear predictor of VIP T1 time, and RVCI was the only addi-
tional significant parameter in bilinear regression.
As a consequence of ventricular interdependence, PH im-
pairs both RVand LV function [19–24]: Progressive RV dila-
tation shifts the IVS toward the LV, successively altering LV
geometry and contractility [17, 18, 25–29]. LV deformation
and paradoxical IVS motion have been shown to lead to high
levels of stress at VIPs [5, 30], which in turn affect the regional
architecture of myocardial tissue [4, 23, 31, 32]. Disarrayed
myocardium containing plexiform fibrosis, where collagen
volume is increased between myocardial fibres but does not
replace them, has been reported from autopsies of PH patients
Fig. 4 Linear regression of septal (a), lateral (b) and global (c)
myocardial T1 times on VIP T1 time in all subjects. Correlation
coefficient r is given together with 95 % confidence intervals (CIs) in
parentheses; SD denotes the standard deviation of residuals from the
regression line
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[4, 32]. In a recent experimental large-animal model study of
chronic PH [33], native T1 values at the VIPs have been dem-
onstrated to be increased due to increased interstitial collagen
associated with fibre disarray.
Accordingly, we presume that the significantly higher VIP
T1 times found in patients with PH can be explained by focal
myocardial remodelling in all (anterior and posterior) VIPs at
the basal, mid-ventricular and apical levels.
To lessen the impact of interobserver variability, analysis
was restricted to mean VIP T1 times. In agreement with rela-
tionships previously reported between LGE volume and hemo-
dynamic, function, mass and geometry parameters [3–5, 29],
univariate analysis of VIP T1 times revealed various significant
correlations with these parameters. VIP T1 time correlated
most strongly with LVEI in patients with PH. Interpreting the
magnitude of VIP T1 as a measure of progression of myocar-
dial remodelling comparable with the extent of LGE at VIPs,
this result is in accordance with findings of Sato et al. [29], who
identified paradoxical IVS motion as the sole predictor of LGE
at VIPs. The appearance of RVCI as an additional predictive
variable in PH patients might indicate the interrelationship be-
tween myocardial remodelling at the VIPs and progression of
right heart failure under the condition of right heart pressure
overload [4, 6]. Furthermore, no differences in VIP T1 times
were found between PAH and non-PAH PH patients, which is
in accordance with the aetiology independence of LGE at VIPs
observed previously [29, 32, 34].
In our study, alterations of LV myocardial T1 times in pa-
tients with PH were not limited to the VIPs and IVS. T1 times
were higher in PH patients in all LV segments, whereas sig-
nificance was reached for all but the apical lateral segment.
Segmental averaging reduced variances of determined T1
times, such that septal, global and lateral T1 values were all
significantly higher in patients with PH than in patients with-
out PH. No differences were found between PAH and non-
Table 3 Correlation of septal, lateral, global and VIP T1 times with
hemodynamic, ventricular function, mass and geometrical parameters for
all and PH patients. Values are correlation coefficients
Parameter VIP T1 Septal T1 Lateral T1 Global T1
All PH All PH All PH All PH
mPAP 0.78 0.62 0.58 0.34 0.42 0.13 0.50 0.23
sPAP 0.73 0.50 0.53 0.20 0.38 0.01 0.45 0.08
dPAP 0.80 0.67 0.62 0.43 0.47 0.25 0.55 0.34
PAWP 0.12 -0.07 0.16 -0.01 0.09 -0.11 0.12 -0.06
RAP 0.39 0.25 0.32 0.19 0.21 0.03 0.30 0.16
PVR 0.75 0.59 0.53 0.32 0.40 0.15 0.47 0.23
mBP -0.12 -0.01 -0.09 0.00 -0.10 -0.06 -0.10 -0.05
sBP -0.43 -0.43 -0.31 -0.32 -0.29 -0.27 -0.31 -0.33
dBP 0.00 0.10 0.00 0.08 -0.01 0.02 0.00 0.05
RVEDVI 0.31 0.14 0.41 0.33 0.27 0.22 0.35 0.27
RVESVI 0.48 0.32 0.53 0.44 0.36 0.29 0.46 0.37
RVSVI -0.37 -0.46 -0.24 -0.25 -0.20 -0.16 -0.23 -0.23
RVEF -0.63 -0.54 -0.57 -0.47 -0.38 -0.29 -0.50 -0.40
RVCI -0.17 -0.35 -0.08 -0.13 -0.03 -0.07 -0.06 -0.10
RVMMI 0.68 0.55 0.68 0.62 0.48 0.41 0.59 0.51
LVEDVI -0.10 -0.03 0.04 0.08 -0.06 0.00 -0.05 -0.01
LVESVI 0.17 0.22 0.27 0.31 0.18 0.24 0.20 0.26
LVSVI -0.34 -0.30 -0.22 -0.22 -0.29 -0.27 -0.30 -0.30
LVEF -0.37 -0.37 -0.39 -0.40 -0.30 -0.31 -0.35 -0.38
LVCI -0.20 -0.26 -0.09 -0.12 -0.15 -0.20 -0.16 -0.19
LVMMI 0.22 0.42 0.36 0.53 0.21 0.34 0.28 0.45
VMR 0.60 0.44 0.51 0.43 0.38 0.29 0.46 0.35
LVEI 0.79 0.72 0.67 0.60 0.49 0.38 0.62 0.54
LVCR -0.75 -0.56 -0.65 -0.51 -0.50 -0.35 -0.58 -0.42
Fig. 5 Linear regression of VIP T1 time on LVEI in patients with PH.
Correlation coefficient r is given together with 95 % confidence intervals
(CIs) in parentheses; SD denotes the standard deviation of residuals from
the regression line
Fig. 6 Box plot of non-normalized septal, lateral, global and VIP T1
values in patients with and without PH. Mean values and standard
deviations are specified in ms; p values are given above brackets for the
corresponding comparisons of non-PH and PH subjects
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PAH PH patients. We conjecture that the presence of higher
T1 times throughout the LV myocardium in patients with PH
could be related to interstitial fibrosis; in turn, such fibrosis
could explain the increased LV wall stiffness, the reduced LV
longitudinal contractility and the reduced circumferential
strain even at LV non-septal segments reported in patients
with chronic PH [17, 20, 21].
The current study cannot unmask the underlying mecha-
nisms leading to LV tissue alterations. However, given that
VIP T1 time was strongly correlated with septal, global and
lateral T1 times and no simple multilinear model of hemody-
namic, ventricular function, mass and geometrical parameters
could similarly predict these T1 values, it appears that PH
involves the total LV myocardium to a large extent in parallel.
This is compatible with the fact that VIP, septal, global and
lateral T1 times showed similar significances in univariate
correlations with hemodynamic, ventricular function, mass
and geometrical parameters. Especially, significant correla-
tions of lateral T1 times with RVMMI, RVEDVI, RVESVI
and RVEF can be understood in this context, as these RV
parameters are related tomPAP and PH.Moreover, consistent-
ly, neither PAWP as a surrogate for left atrial pressure, nor LV
functional parameters exhibited dominant association with
septal, global or lateral T1 times similar to the association of
these parameters with VIP T1 times.
Segmental, myocardial and VIP T1 times were normalized
to the mean blood T1 time of the study population. The blood
normalization coefficient k=0.30 derived from healthy volun-
teers at 3Twas expectedly different from the one at 1.5T [15].
Blood normalization by trend did not change group differ-
ences or correlations. However, blood normalization de-
creased variances of T1 times in the study population as well
as in PH and non-PH subgroups and, moreover, enhanced
differences in mean T1 times between PH and non-PH groups
by eliminating differences in blood T1 times. The impact was
largest for lateral T1 times: Whereas only by trend higher in
PH compared to non-PH subjects, differences became highly
significant after blood normalization.
Study limitations
The present study had a number of limitations. A non-contrast
CMR protocol was applied, and, therefore, LGE and post-
contrast T1 times could not be assessed. Analysis of LGE
volume would have allowed proving the association of VIP
T1 with the extent of LGE at VIPs. Post-contrast T1 and
calculation of ECV might have provided additional informa-
tion on the underlying nature of tissue alterations observed in
native T1, as a recent pre-clinical study [33] suggests eleva-
tion of both native T1 and ECV in PH. Histological evaluation
of the myocardium was lacking. Moreover, because recon-
structed T1 maps were not applicable for evaluation of RV
T1 times, RV myocardium could not be analyzed.
Myocardial T1 times were blood-normalized based on a blood
normalization coefficient determined from a healthy but not
age-matched group. Blood normalization coefficient might
vary with age; however, this would lead only to some minor
remaining impact of blood T1 time in the results. Finally, the
studied population was restricted to pre-capillary PH, but
consisted of clinical PH groups of different sizes.
Comparison of PAH and non-PAH PH patients did not reveal
significant differences in T1 times. However, larger-scale
studies are needed to investigate possible aetiology depen-
dence of LV myocardial remodelling based on native T1 time
alterations.
Conclusions
In patients with PH, T1 times in VIPs and also in the entire LV
myocardium are elevated. LV eccentricity strongly correlates
with VIP T1 time, which in turn is strongly associated with T1
time changes in the entire LVmyocardium. Further research is
needed to determine if elevated LV T1 times have prognostic
importance in patients with PH.
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